Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CL 316243 free acid
Cat. No.:
OB0425LY-049
Appearance:
Solid
Purity:
99.37%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
CL 316243 free acid is a selective beta3-adrenergic receptor agonist with excitatory effects on lipid metabolism.
Synonyms:
183720-02-7; 1,3-Benzodioxole-2,2-dicarboxylic acid, 5-((2R)-2-(((2R)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)-; 5-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)-1,3-benzodioxole-2,2-dicarboxylic acid
CAS No.:
183720-02-7
Compound CID:
5486546
Formula:
C20H20ClNO7
Formula Weight:
421.83
Specification
Target:
Adrenergic receptor
Pathway:
GPCR/G protein; Neuronal signaling
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
CL 316243 free acid is mainly used to study diseases related to metabolic syndrome, diabetes and obesity.
